The LIC who originally advised me of the problems ACR were going to encounter yesterday came up with a target price of $1.50. They expect a short term recovery before going lower.
Apparently most of the original people who were responsible for Axiron hitting the market have since left the company & the CEO is more or less running the company himself.
It is now mostly left to Eli Lilly to try & expand the market for Axiron.
The LIC is continuing to short the stock.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 335415 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 516258 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |